CRCA vs. JMST
CRCA (ProShares Ultra CRCL) and JMST (JPMorgan Ultra-Short Municipal Income ETF) are both exchange-traded funds - CRCA is a Leveraged Equities fund actively managed by ProShares, while JMST is a Ultrashort Bond fund actively managed by JPMorgan. Both are actively managed. At a correlation of -0.05, they often move in opposite directions. CRCA charges 0.95%/yr vs 0.18%/yr for JMST.
Performance
CRCA vs. JMST - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CRCA achieves a -56.81% return, which is significantly lower than JMST's 1.13% return.
CRCA
- 1D
- -13.29%
- 1M
- -64.42%
- YTD
- -56.81%
- 6M
- -60.16%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
JMST
- 1D
- 0.00%
- 1M
- 0.38%
- YTD
- 1.13%
- 6M
- 1.18%
- 1Y
- 2.88%
- 3Y*
- 3.35%
- 5Y*
- 2.30%
- 10Y*
- —
CRCA vs. JMST - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
CRCA ProShares Ultra CRCL | -56.81% | -84.67% |
JMST JPMorgan Ultra-Short Municipal Income ETF | 1.13% | 1.15% |
Correlation
The correlation between CRCA and JMST is -0.05, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Aug 7, 2025 | -0.05 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CRCA vs. JMST — Risk / Return Rank
CRCA
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
JMST
CRCA vs. JMST - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ProShares Ultra CRCL (CRCA) and JPMorgan Ultra-Short Municipal Income ETF (JMST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CRCA | JMST | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | — | 2.42 | — |
| Calmar ratioReturn relative to maximum drawdown | — | 11.34 | — |
| Martin ratioReturn relative to average drawdown | — | 61.62 | — |
Loading charts...
Drawdowns
CRCA vs. JMST - Drawdown Comparison
The maximum CRCA drawdown since its inception was -94.31%, which is greater than JMST's maximum drawdown of -2.41%. Use the drawdown chart below to compare losses from any high point for CRCA and JMST.
Loading charts...
Drawdown Indicators
| CRCA | JMST | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -94.31% | -2.41% | -91.90% |
Max Drawdown (1Y)Largest decline over 1 year | — | -0.25% | — |
Max Drawdown (3Y)Largest decline over 3 years | — | -0.71% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -1.15% | — |
Current DrawdownCurrent decline from peak | -93.38% | 0.00% | -93.38% |
Average DrawdownAverage peak-to-trough decline | -71.83% | -0.12% | -71.71% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 0.05% | — |
Volatility
CRCA vs. JMST - Volatility Comparison
Loading charts...
Volatility by Period
| CRCA | JMST | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 0.19% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 0.42% | — |
Volatility (1Y)Calculated over the trailing 1-year period | 194.72% | 0.60% | +194.12% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 194.72% | 0.83% | +193.89% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 194.72% | 1.13% | +193.59% |
CRCA vs. JMST - Expense Ratio Comparison
CRCA has a 0.95% expense ratio, which is higher than JMST's 0.18% expense ratio.
Dividends
CRCA vs. JMST - Dividend Comparison
CRCA's dividend yield for the trailing twelve months is around 4.01%, more than JMST's 2.65% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
CRCA ProShares Ultra CRCL | 4.01% | 1.06% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
JMST JPMorgan Ultra-Short Municipal Income ETF | 2.65% | 2.84% | 3.32% | 3.09% | 1.10% | 0.27% | 0.87% | 1.63% | 0.28% |
Frequently Asked Questions
CRCA and JMST have a correlation of -0.05, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, JMST is cheaper at 0.18% per year. The better choice depends on whether you care most about return, fees, risk, or income.
JMST is cheaper with a 0.18% expense ratio, compared with 0.95% for CRCA.
CRCA has the higher dividend yield at 4.01%, compared with 2.65% for JMST.
CRCA is categorized as Leveraged Equities, while JMST is Ultrashort Bond. They also come from different issuers: ProShares and JPMorgan. Their fees differ too: 0.95% for CRCA and 0.18% for JMST.
Find the right allocation for CRCA and JMST
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer